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1. Introduction
NMR and MRI are among the most versatile and
successful methods in medical and natural sciences. Despite
their great success, however, the signal to noise ratio (SNR) of
NMR and MRI remains a limiting factor for many applica-
tions, such as proteomics and metabolomics. Consequently,
significant effort has been invested in increasing the signal
and lowering the noise, such as by designing stronger magnets,
matching probes and sample size, and using cryogenically
cooled detectors.[1, 2]
One approach to boost the signal by several orders of
magnitude is the hyperpolarization of nuclear spins. Here, the
population difference of the energy states of spins in
a magnetic field is dramatically increased. This method leads
to unprecedented signal to noise enhancements[3–7] and can
achieve 10% polarization or more.[8,9] To put these numbers
into context: 10% 13C polarization is equivalent to a signal
enhancement of 10000-fold at 11.7 T or about 100000-fold at
1.5 T.
Hyperpolarization techniques have significantly advanced
breakthrough applications such as real-time metabolic imag-
ing,[10] high-resolution NMR, and solid-state NMR.[11, 12]
Among these applications, the hyperpolarization of amino
acids (AAs) and peptides is particularly interesting, although
not fully explored. AAs, as the building blocks of proteins,
play essential roles in regulation and metabolism. As a con-
sequence of the robustness and versatility of solid-phase
peptide synthesis (SPPS)[13] and the pharmacological impor-
tance of peptide-based drugs, employing hyperpolarized
peptides as markers in magnetic resonance imaging or
biophysical studies has immense technical potential.
Despite the enormous signal enhancement provided by
hyperpolarization, the SNR of hyperpolarized MRI is usually
low, thereby resulting in limited spatial and chemical reso-
lution.[14–16] The reason for the low SNR is relaxation,
substantial dilution of the hyperpolarized agent when applied
in vivo, and the fact that you can only encode the magnet-
ization once, as it is not replenished. To achieve the desired
SNR, enough and sufficiently polarized agents must reach the
area of interest. Thus, one of the key challenges is to highly
polarize a concentrated sample (some-
times measured in molar polarization,
the product of polarization and con-
centration).
It has been estimated that the
minimum 13C polarization for a sin-
gle-scan detection of l-3,4-dihydroxy-
phenylalanine (l-DOPA), a precursor
for several neurotransmitters in the
human brain, is about 0.1%.[17] For
in vivo studies, however, the polariza-
tion and concentration of the injected
agent often exceed 20% and 100 mm,
respectively.[18,19] l-DOPA can readily
cross the blood–brain barrier and can
convert into dopamine within 15 s.[20]
Several other AAs and peptides
have been polarized with dynamic
nuclear polarization (DNP)16] or chem-
ically induced dynamic nuclear polarization (CIDNP).[3]
Alanine ethyl ester, alanine, aspartate, serine, and lysine
were polarized to more than 20% and found to have a pH-
dependent chemical shift suitable for pH imaging.[21–23] The
metabolic conversion of DNP-polarized alanine into lactate,
pyruvate, and bicarbonate has been observed in the liver and
the heart of healthy mice within one minute.[23] Imaging
alanine transaminase activity may be a biomarker for
pathologies such as cancer, inflammation, and infections.[24]
The arginase-mediated breakdown of hyperpolarized argi-
Nuclear magnetic resonance (NMR) has become a universal method
for biochemical and biomedical studies, including metabolomics,
proteomics, and magnetic resonance imaging (MRI). By increasing the
signal of selected molecules, the hyperpolarization of nuclear spin has
expanded the reach of NMR and MRI even further (e.g. hyper-
polarized solid-state NMR and metabolic imaging in vivo). Para-
hydrogen (pH2) offers a fast and cost-efficient way to achieve hyper-
polarization, and the last decade has seen extensive advances,
including the synthesis of new tracers, catalysts, and transfer methods.
The portfolio of hyperpolarized molecules now includes amino acids,
which are of great interest for many applications. Here, we provide an
overview of the current literature and developments in the hyper-
polarization of amino acids and peptides.
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nine to urea and ornithine has been demonstrated in myeloid-
derived suppressor cells (MDSCs) and may be used to image
inflammation.[25] CIDNP-polarized arginine has been applied
for studying protein folding and to investigate the properties
of AAs and protein radicals.[26] These studies demonstrate
that the applications of hyperpolarized AAs are manifold,
ranging from protein studies to cell cultures and living
organisms.
Another hyperpolarization method is parahydrogen-in-
duced polarization (PHIP, Figure 1). The pioneering studies
of Bowers andWeitekamp[27,28] as well as Eisenschmid et al.[29]
have led to numerous applications of PHIP in catalysis,
analytical chemistry, and biomedicine.[30,31] The advantages of
PHIP are the fast and low-cost production of hyperpolarized
agents; the disadvantages include the sometimes limited
polarization yield as well as the need for a catalyst and
chemical reaction. The separation of the catalyst and hyper-
polarized agent is essential but challenging; catalyst filtra-
tion[30] and the utilization of heterogeneous or immobilized
catalysts have been suggested as ways to address this
matter.[32]
Several recent advances have led to PHIP increasingly
becoming a method of choice for the polarization of many
molecules at low cost and high throughput. The hyperpola-
rization of amino acids with PHIP is of particular interest for
biochemistry and MR-imaging. This is the focus of this
Minireview.
2. Principles of PHIP
2.1. Background and Preparation
PHIP is based on the spin order of pH2. There are many
variants of the method, but most feature two essential steps:
the incorporation of spin order to a target molecule and
converting that order into observable polarization (Figure 1).
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pH2 is a convenient source of spin order as it is quickly
produced in large quantities and has a long lifetime. Consist-
ing of two protons (spin-1=2 particles), molecular dihydrogen
H2 follows the Fermi–Dirac statistics. Hence, the total wave
function must change sign when the protons are interchanged.
The result is two spin isomers: parahydrogen (pH2) and
orthohydrogen (oH2). For pH2, the nuclear spin wave function
is antisymmetric, and the remaining part is symmetric; thus,
the rotational quantum number is even: J= 2n. oH2, on the
other hand, has a symmetric nuclear spin state and antisym-
metric rotational states (J= 2n+ 1). As a result, there is one
antisymmetric (singlet, para) nuclear spin state and three
symmetric spin states (triplet, ortho). The energy difference
between the ground rotational states J= 0 and J= 1 is much
larger than the thermal energy at room temperature (about
120 cm1),[33] such that the [oH2]/[pH2] ratio is 3:1. At 77 K,
the ratio is already close to 1:1, while at 25 K it is 1:99.
Several instruments have been developed to aid the
production of pH2.
[34–36] As the oH2–pH2 transition is for-
bidden under conservation of quantum numbers, a conversion
catalyst such as FeO(OH) is used. Once produced, pH2 may
be conveniently stored in a bottle and used on demand.
2.2. Polarization
For hyperpolarization, pH2 is either added permanently
[37]
to a target molecule or brought into temporary contact.[38]
This chemical reaction can be carried out in a test tube[37, 38] or
in a more dedicated automated system: a stand-alone polar-
izer[39–44] or a reaction chamber in an MR system.[8,45–47] For
high and reproducible polarizations, such systems are cru-
cially important.
Hydrogenation at high magnetic fields is usually referred
to as a PASADENA experiment.[28,29] In contrast, hydro-
genation at low magnetic fields and subsequent transfer to
high field is often called ALTADENA.[37]
pH2, however, has spin 0 and is NMR silent. The
conversion of this spin order into observable magnetization
may take place spontaneously, as the spins evolve, or it may
be aided by radio-frequency (RF) pulses[48] or variations of
the magnetic field (field cycling).[40, 49–51] Whereas detection of
a 1H signal may be sufficient for in vitro analysis,[52, 53] in vivo
application usually necessitates transfer to a slow-relaxing X-
nucleus such as 13C or 15N.[40, 54,55]
2.3. Variations
For a long time, hydrogenative PHIP was severely
hindered by the need for dedicated precursor molecules. This
need was ameliorated by PHIP side-arm hydrogenation
(PHIP-SAH),[56] signal amplification by reversible exchange
(SABRE),[38] and recently SABRE-RELAY[57] and PHIP-
X.[58] Most of these methods can be used to hyperpolarize
AAs and peptides, as discussed in the following sections.
3. PHIP of Amino Acids
3.1. PHIP of AAs by Direct Hydrogenation
The most direct way to hyperpolarize AAs by PHIP is the
hydrogenation of a suitable precursor. This approach was
used to hyperpolarize g-aminobutyric acid (GABA) in water
using trans-aminocrotonic acid as a precursor (Figure 2).[60]
Here, the water-soluble catalyst 1,4-bis-[(phenyl-3-propane
sulfonate)phosphine]butane(norbornadiene)rhodium(I) tet-
rafluoroborate was used for homogeneous hydrogenation[30]
at pH= 2.54. However, only a small signal enhancement of
GABAwas found (SNR of 3–10). Fast catalyst degradation at
low pH values and a low hydrogenation yield were reported
Figure 1. Parahydrogen-based hyperpolarization: Schematic view of
the spin states of dihydrogen (a,b), their populations at >300 K and
ca. 25 K (c), as well as the basic reactions of hydrogenative (d) and
non-hydrogenative (e) hyperpolarization. The nuclear spins of dihydro-
gen form four different spin states: three ortho (triplet: T+, T0, T; a),
and one para state (singlet, S; b). At room temperature, all four states
are approximately equally populated (c). By cooling the H2, the
equilibrium is shifted toward the para state and almost pure pH2 is
obtained at ca. 25 K (c).[33, 59] To use the NMR-invisible para order, pH2
is added either permanently to an unsaturated molecule (d,e), or
brought into temporary contact through reversible exchange (f). Next,
the spin order is converted spontaneously (free evolution) into
observable polarization (pol) induced by RF pulses or variations of the
magnetic field. The polarization may be observed on the added
hydrogen atoms or transferred to other nuclei.
Figure 2. PHIP of AAs by direct hydrogenation.[60] In this example, pH2
is added to trans-aminocrotonic acid (TACA) by homogeneous hydro-
genation to yield GABA. Although the hydrogenation was successful,
only a low signal enhancement was found at pH 2.54, and none was
observed at neutral pH.
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to be possible reasons. No hyperpolarization was found at
neutral pH.
Obtaining other precursors for AAs, however, is challeng-
ing due to keto-enol tautomerization. Protection of the amino
group of AAs or derivatives was suggested as a solution to this
problem.[17, 61,62] For example, 2-acetamidoacrylate was hydro-
genated with pH2 to yield N-acetyl-dl-alanine methyl ester
with [Rh(dppb)(COD)]BF4 (dppb= 1,4-bis(diphenylphos-
phino)butane, COD= 1,5-cyclooctadiene) in D2O (Fig-
ure 3).[62] It was also demonstrated that the solubility of the
reagent was improved by adding 4.2–14.7 mm sodium dodecyl
sulfate (SDS),[63] with 12.6 mm SDS resulting in the highest
signal.
In a different study, four N-acetyldehydroamino acids
were synthesized, namely, precursors for N-acetylphenylala-
nine (Figure 4), N-acetyltryptophan (and N-acetyl-5-
methoxytryptophan), N-acetyltyrosine (and (2S)-2-acetami-
do-3-(3,4-dihydroxyphenyl) propanoic acid), andN-acetylhis-
tidine as well as their D (2H) and 13C isotopomers.[17]
Hydrogenation was performed in CD3OD or D2O containing
SDS and [Rh(dppb)(COD)]BF4.
[17] The achieved proton
polarization levels were in the range of P(1H)= 0.4–1.1%,
where protonated precursors provided the highest polariza-
tion P(1H)= 0.76–1.1% for phenylalanine as well as tyrosine
and its derivative. For these AA precursors, the hydrogena-
tion rate was about ten times higher than for the others, which
was tentatively attributed to faster hydrogenation of electron-
poor alkenes.[64] Deuteration of the phenylalanine precursor
increased the polarization and T1 value from 0.76% to 2.05%
and 1.6 s to 3.3 s, respectively. Using PH-INEPT+ ,[33] the
polarization was then transferred to the 13C-carboxy group,
thereby resulting in 1.3% 13C polarization.
3.2. PHIP of Peptides by Side-Chain Hydrogenation (PHIP-Label)
In an alternative approach, non-natural, unsaturated
amino acid building blocks were designed for the direct
addition of pH2.
[60] PHIP-active peptides can be prepared by
direct SPPS synthesis by employing amino acid building
blocks protected with fmoc (fluorenylmethoxycarbonyl) pro-
tecting groups and PHIP active groups.
To preserve the conformational freedom of the backbone,
it was found advantageous to place the necessary unsaturated
groups, such as, allyl or propargyl groups, into a side chain. A
simple realization of this PHIP-label approach was achieved
using allylglycine and propargylglycine. Here, the use of the
propargyl group is convenient because it allows two hydro-
genations.
Kçrner et at.[65] evaluated the feasibility of this approach
with propargylglycine (Pra). They studied the PHIP activity
of a series of tripeptides. Specific amino acid combinations,
such as Ala-Pra-Ala, Phe-Pra-Phe, or Met-Pra-Met yielded
substantial signal enhancements, although an order of mag-
nitude or so smaller than those achieved with neat Pra. Other
combinations of sulfur-containing amino acid residues, such
as Cys-Pra-Cys, did not show any PHIP enhancement. They
showed that this approach can also be applied to larger
oligopeptides by employing two different decapeptides.
Recently, Bouchard and co-workers demonstrated the hydro-
genation of propargylglycine to form allylglycine by using
a ligand-stabilized heterogeneous Pd-NP catalyst.[66] Al-
though these results clearly showed the high potential of this
technique for biomedical applications, it has become clear
that using Pra as the PHIP label is not generally suitable.
Sauer et al.[68] found that isolating the triple bond within
the respective label and ensuring its accessibility to the
hydrogenation catalyst were essential factors in controlling
the resulting signal enhancement. In particular, the use of O-
propargyl-l-tyrosine yielded substantial enhancements of the
1H NMR signal in an aqueous solution (P(1H)= 1.5%).[68]
They showed that this label could be introduced at any
position in a peptide chain by SPPS without side-chain
protection. Such labeling was exemplified with a bioactive
derivative of the sunflower trypsin inhibitor-1 (SFTI-1).[13]
SFTI-1, a disulfide-bridged cyclic tetradecapeptide (Figures 5
and 6) found in nature,[36–38,69–71] is a very potent inhibitor of
serine protease trypsin[71, 72] and is applied for tumor diag-
nostics and treatment.[73, 74]
Manual ALTADENA[37] experiments with a propargyl-
functionalized tyrosine mutant of SFTI-1[68] revealed a 70-fold
signal enhancement of the protons in the O-allyl-l-tyrosyl
unit, with the inhibitory activity of the peptide also preserved.
Under PASADENA conditions, an automated PHIP
setup with higher pH2 pressures
[75] allowed the enhancement
factors of propargyl-SFTI-1 to be increased to about 1200
(P(1H)= 9.6%; Figure 6).[75] The reproducibility of this setup
enabled PHIP-enhanced 2D NMR experiments, which are
usually difficult because of variations in the polarization yield.
Figure 3. PHIP of protected AA derivatives by direct hydrogenation. In
this example, methyl 2-acetamidoacrylate is hydrogenated to N-acetyl-
dl-alanine methyl ester.[62]
Figure 4. PHIP of N-acetyldehydroamino acids by direct hydrogena-
tion.[17, 61] 14 mm 13C-1-N-acetylphenylalanine precursor was hydrogenat-
ed in 350 mm CD3OD in the presence of 0.7 mm [Rh(dppb)(COD)]BF4.
The maximum polarization for the fully deuterated precursor was
P(1H)=2.05% and P(13C)=1.3%. Other hydrogenation reactions were
demonstrated for N-acetyltyrosine, N-acetyltryptophan, N-acetylhisti-
dine,[17] and the antibiotic thiostrepton.[61]
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To address this issue, ultrafast 2DNMR methods were
suggested (Figure 6),[67, 76,77] as pioneered by the Frydman
group.[78–81] Ultrafast 2D NMR combines ideas from NMR
andMRI, for example, the slice-wise acquisition of spectra for
swift biochemical analysis.
3.3. PHIP of AA Derivatives by Side-Arm Hydrogenation (PHIP-
SAH)
One severe limitation of PHIP was the need for an
unsaturated precursor that could be hydrogenated to form the
desired product (e.g. an AA). Such precursors may be
unavailable or unstable. A solution[49, 82] found by Aime and
co-workers is based on the addition of an unsaturated side
arm to the desired molecule (PHIP-SAH) through an ester
bond. After adding pH2 to the side arm, the polarization is
transferred to the primary molecule, and the side arm is
cleaved off. As an added benefit, a catalyst-free aqueous
solution of the target molecule is obtained by spontaneous
separation into an organic and aqueous phase after cleavage.
PHIP-SAH led to P(13C) 5% for aqueous pyruvate[56] after
cleavage and was used to monitor its transformation into
lactate in an enzyme solution, in suspensions of cancer cell
lines,[83, 84] and in mice.[55]
PHIP-SAH of AAs was demonstrated by Glçggler
et al. ,[85] who esterified the carboxy groups with hydroxyethyl
acrylate and then deprotected the amine group. The resulting
amino acid derivatives (Figure 7) showed typical polarization
on the order of P(1H)= 1% in an aqueous solution.[85]
PHIP-SAH was also combined with heterogeneous
(HET) catalysis.[86] Here, a virtually catalyst-free solution
was obtained by the gas-phase hydrogenation of vinyl acetate
over an Rh/TiO2 powder, with subsequent condensation or
dissolution of the hyperpolarized ethyl acetate and its
hydrolysis.[87]
The combined HET-PHIP-SAH approach has been
demonstrated for AAs as well (Figure 8).[88] To this end,
[D3]vinyl esters of alanine and glycine (1-
13C-labeled) were
synthesized by transesterification of the corresponding N-
protected amino acids. The final unprotected amino acid
esters were hydrogenated over a heterogeneous catalyst in
D2O. The presence of DCl in the sample was essential to
suppress the rapid decomposition of the substrates. This
procedure yielded a 1H polarization of about 1% for the
resulting ethyl esters. Subsequent polarization transfer in-
duced by RF fields provided 0.65% and 0.8% 13C polarization
of the carbonyl carbon atom of the alanine and glycine ethyl
esters, respectively. Hydrolysis of the ester bond with added
NaOD resulted in a further decline in the 13C polarization to
Figure 5. PHIP of peptides by hydrogenation of a side chain (PHIP-
label). In this example, a propargyl moiety was added to tyrosine in
a peptide. The addition of pH2 results in hydrogenation of propargylty-
rosine to yield a hyperpolarized allyltyrosine peptide. In the sunflower
trypsin inhibitor SFTI-1, polarizations of P(1H)=9.6%[67] were obtained
in the allyl product (right).
Figure 6. PHIP of large peptides by direct hydrogenation of a side chain (PHIP-label). SFTI-Tyr(O-propargyl) was hydrogenated in [D4]MeOH with
[Rh(dppb)(COD)]BF4 : A) 1D NMR (0.96 mm precursor and 4.1 mm catalyst) and B) ultrafast 2D PHIP-TOCSY (10 s 3 bar pH2, single scan, 5 mm
precursor, and 2.5 mm catalyst). Signals marked with an asterisk (*) are impurities (adapted from Sauer et al.[68] and Kiryutin et al.[67]). For
assignment of the side-chain protons of the allyl moiety see Figure 5.
Figure 7. PHIP of AA derivatives through side-arm hydrogenation
(PHIP-SAH). In this example, a protected alanine ethyl acrylate ester
was hydrogenated to yield alanine ethyl propanoate in an aqueous
solution.[85] Polarizations of P(1H)=0.70% and P(13C,*)=4.4% (for
a deuterated vinyl group) were achieved at 80 8C and pH 6.50.5.
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about 0.25% and 0.29% for alanine and glycine, respectively.
Further workup of the resulting slurry, including the removal
of the nanoparticulate catalyst, has not been attempted so far.
3.4. PHIP of AAs by SABRE
In 2009, the PHIP technique termed signal amplification
by reversible exchange (SABRE) was described.[38] SABRE
creates hyperpolarized substrates without changing their
chemical identity. SABRE releases the latent polarization of
pH2 through its reversible binding to a metal complex,
whereby the magnetic symmetry of its two hydrogen atoms is
broken (Figure 9). Ligands within the coordination sphere of
the catalyst then become hyperpolarized by spin-order trans-
fer through the scalar coupling network.[89] However, disso-
ciation of a ligand or the substrate (sub, Figure 9) is required if
the aim is to build-up finite concentrations of a hyperpolarized
material in solution.[90, 91] The timescales of SABRE make it
a very rapid hyperpolarization method that can create very
high levels of polarization in seconds as well as continuous
hyperpolarization.[53, 92,93] Although its use with amino acids is
still in its infancy, many other systems have been examined
with great success.[94]
Polarization “flows” through the
scalar coupling network of the active
complex when it is in an appropriate DC
magnetic field[95] or on RF excitation.[96]
The exact details of this spin-order
transfer have been described theoret-
ically. Its efficiency depends on the
ligand dissociation rates, the spin-order
relaxation rates, and the size of the
propagating spin–spin couplings.[97] For
1H nuclei, optimal polarization transfer
usually results when the sample is
exposed to a static field of around
6 mT.[98] For 15N transfer, however, the
larger 1H-15N scalar couplings and dif-
ferences in the involved magnetogyric
ratio act to reduce the necessary field to around 200 nT.
Consequently, SABRE catalysis must now take place inside
a magnetic shield,[51] a refinement termed SABRE-SHEATH
(signal amplification by reversible exchange in shield enables
alignment transfer to heteronuclei). This is important for
studies on amino acids if 15N is to be optimally detected.[51,99]
Ligand dissociation from the active complex is vital for
“refreshing” the latent spin order of the pH2-derived hydride
ligands during SABRE (Figure 9). This implies, for example,
the involvement of short-lived complex [Ir(H)2(h
2-H2)(IMes)-
(py)2]Cl when the substrate is pyridine (py; IMes= 1,3-
bis(2,4,6-trimethylphenyl)imidazol-2-ylidine). Density func-
tional theory (DFT) methods have confirmed this.[91] The
reversible binding of a targeting reagent to the metal center
containing the pH2-derived hydride ligands is, therefore,
critical to spin-order propagation during SABRE. Many of
the iridium catalysts used for SABRE are based on N-
heterocyclic carbenes (NHCs) and exhibit the form [Ir(H)2-
(NHC)(sub)3]Cl. They have delivered gains to the NMR
signals of 1H, 15N, 13C, 19F, 31P, and other nuclear sites in a range
of molecules, including N heterocycles, nitriles, amines, and
many others.[7] The substrate scope of SABRE has, therefore,
been most commonly illustrated for molecules with N-donor
sites that readily ligate to the iridium center. This approach
has been extended to pyridine-tagged biocompatible molec-
ular frameworks, including oligopeptides[100,101] and gly-
cine.[102]
SABRE can involve high symmetry catalysts such as
[Ir(H)2(IMes)(py)3]Cl with chemically equivalent hydride
ligands. Their magnetic inequivalence is responsible for
polarization flow.[91] Complexes where the hydride ligands
become chemically different have also been successfully used.
This situation is readily achieved when a further co-ligand is
present, since complexes of the type [Ir(H)2(IMes)(py)2(co-
ligand)]Cl can now form when the hydride ligands lie trans to
different groups.[103,104]
There are 21 different a-amino acids. They can exhibit
monodentate amine or carboxylate coordination in addition
to forming five-membered chelates when binding takes place
through both moieties (N,O-chelation). However, several
contain additional binding sites in their side chains (e.g. the
imidazole ring of histidine (His), the phenol ring of tyrosine
(Tyr), and the thiol group of cysteine (Cys)). The complex-
Figure 8. PHIP of AAs by heterogeneous PHIP-SAH. Here, unprotected amino acid esters[88]
were hydrogenated over a heterogeneous catalyst (Rh nanoparticles with preadsorbed N-
acetylcysteine) by bubbling 80% pH2 for 30 s through the slurry at 7 bar and 80 8C (0.6–0.9 mm
vinylglycine and vinylalanine in D2O with 56 mm DCl; pH 2). P(
1H)1% was observed on the
resulting ethyl esters; the subsequent RF-induced 1H to 13C polarization transfer yielded
P(13C)=0.65% (ethylalanine) and 0.8% (ethylglycine). The addition of a NaOD solution
effected hydrolysis of the ester bond in less than 10 s and resulted in P(13C)=0.25% (alanine)
and 0.29% (glycine).
Figure 9. Schematic representation of the SABRE process in which pH2
in the presence of an Ir complex hyperpolarizes the substrate.
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ation of amino acids is, therefore, complicated and will be
reflected in any SABRE effects, which could occur through
both types of hydride symmetry breaking processes.
The observation of direct SABRE polarization of
amines[105] and carboxylates, such as acetate[106] and pyru-
vate,[107] via complexes such as [Ir(H)2(IMes)(NH2CH2Ph)3]Cl
and [Ir(H)2(IMes)(py)2(CO2CH3)] and [Ir(H)2(IMes)-
(DMSO)(CO2COCH3) provides confidence that the SABRE
hyperpolarization of amino acids is indeed viable through N,
O-, or N,O-ligation modes.[108] Therefore, not surprisingly, an
early study on SABRE by Appelt and co-workers[109]
suggested that all of the proteinogenic amino acids could be
hyperpolarized in this way. They used [Ir(COD)(PCy3)(py)]-
[PF6] as the SABRE catalyst precursor in [D4]MeOH. The
measurements were carried out with a home-built NMR
spectrometer at proton frequencies of 166 kHz and 10 kHz. It
was suggested that either [Ir(amino acid)2(H)2(PCy3)(py)]-
[PF6] or [Ir(amino acid)(H)2(PCy3)(py)][PF6] is formed, but
these complexes were not observed in solution. An enhanced
1H NMR signal was detected in single-scan measurements of
the samples with histidine, glycine, and phenylalanine. The
enhanced signal was attributed to the hyperpolarized amino
acid, but this work has not been developed further.
3.5. PHIP of AAs by Proton Exchange Using SABRE-RELAY
Recently, the pool of molecules that can be hyperpolar-
ized with pH2 was significantly extended by the introduction
of SABRE-RELAY. Here, the enhancement of a SABRE-
polarized transfer agent is passed on to another molecule
through proton exchange (Figure 10). Amino acids contain
exchangeable amine (NH) and carboxylate protons (COOH).
When the SABRE precatalyst [IrCl(COD)(IMes)] reacts
with ammonia or a suitable amine, complexes of the type
[Ir(H)2(IMes)(NH3)3]Cl
[105] are formed. Such complexes can
hyperpolarize the exchangeable protons of these reagents
(Figure 10). Once they become embedded in a second
molecule, the hyperpolarization can be relayed into the core
of the reagent.[57] This process has been called SABRE-
RELAY and shown to operate successfully on a range of
amines, amides, carboxylic acids, alcohols, phosphates, and
carbonates—again without changing their chemical identity.
The use of DNP-hyperpolarized water as a means to
enhance the sensitivity of nuclei in biomolecules such as
alanine through the exchange has also been reported.[110]
Water has been polarized with parahydrogen in conjunction
with histidine; the observed hydride ligand signals indicate
histidine binding to the SABRE catalyst.[111] The polarization
of the solvent OH protons by SABRE using standard iridium-
based catalysts under slightly acidic conditions has also been
reported.[112] Although this polarization is achieved by the
coherent redistribution of polarization (SABREmechanism),
it is also possible that an exchange pathway involving single
proton spins is feasible.[113] Consequently, there are several
ways in which the successful hyperpolarization of AAs and
peptides can be brought about using SABRE-RELAY.
3.6. PHIP of AAs by Proton Exchange Using PHIP-X
Another method that takes advantage of polarization
transfer by proton exchange was introduced only recently.[58]
Parahydrogen-induced polarization relayed by proton ex-
change (PHIP-X) attempts to combine the advantages of
SABRE-RELAY and PHIP, namely, the broad applicability
of proton exchange and the high polarizations achieved by
hydrogenative PHIP.
In PHIP-X, pH2 is added directly to an unsaturated
precursor with a labile proton (e.g. propargyl alcohol, Fig-
ure 11). The labile proton undergoes exchange and carries the
polarization to the target or receiver molecule, such as water
(P(1H)= 0.36%, 48 mm), ethanol (P(1H)= 0.4%, 28 mm),
propargyl alcohol (P(1H)= 0.41%, 25 mm), pyruvic acid
(P(1H)= 0.009%, 120 mm), or lactic acid (P(1H)= 0.07%,
29 mm). Polarization transfer from the nascent pH2 protons to
the labile proton was demonstrated by variation of the
magnetic field, much in the way of the classic ALTANDE-
NA[37] experiment or SABRE-RELAY.[57] However, other
methods may also prove beneficial.
The 1H polarization of the transfer agent was very high,
exceeding 13%. However, each precursor can be hydro-
Figure 10. Schematic representation of the SABRE-RELAY process. This
catalytic cycle enables the hyperpolarization of a target substrate, such
as the alcohol ROH, through the transfer of SABRE-polarized protons
from a transfer agent with labile protons, such as the illustrated amine
RtNH2. Here, R is a suitable polarization receptor, e.g. CH3 or CH2-
phenyl.
Figure 11. Scheme of parahydrogen-induced polarization relayed by proton exchange (PHIP-X). First, an unsaturated transfer agent (propargyl
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genated and, thus, used only once. SABRE-RELAY, instead,
allows continuous re-hyperpolarization and possibly signal
accumulation or averaging.[53, 92,93] PHIP-X appears to apply to
AAs in the same way as SABRE-RELAY, since many AAs
feature exchangeable protons. Difficulties arise from the fact
that AAs are poorly soluble in many solvents, including those
beneficial for PHIP-X and SABRE-RELAY. For example,
water and alcohol are poor choices as solvents because they
act as receiver molecules. Furthermore, the catalyst may
hinder the proton exchange, and both the precursor and
transfer molecule may serve as a receiver of exchanging
hydrogen atoms, thereby reducing the polarization of the
target molecule.
4. Conclusion and Outlook
Several recent advances have enabled the synthesis and
hyperpolarization of protected AAs and derivatives. The
hydrogenation of side chains (PHIP-label) and side arms
(PHIP-SAH) has drastically enlarged the pool of available
agents, now also including nonprotected AAs, peptides, and
proteins. SABRE allows direct polarization of proteinogenic
AAs or pyridine-tagged AAs and oligopeptides without
altering their chemical identity. SABRE also has been
successfully utilized to reveal the composition of biofluids
with an analyte concentration as low as 0.5 mm.[52]
The transfer of polarization by proton exchange is a new
route for the polarization of AAs. For example, proton
exchange of hyperpolarized water recently helped to trace
RNA refolding induced by hypoxanthine.[114] We foresee that,
in the same manner, pH2-hyperpolarized water or other
transfer agents such as NH3 or allyl alcohol could be utilized
in analytical chemistry to probe AAs and peptides.
The hyperpolarization of AAs has never been easy with
PHIP. First and foremost, suitable precursors are rare.
However, this picture is about to change as new precursors
are found, new protection schemes designed, and derivatives
synthesized. New methods to overcome the need for unsatu-
rated precursors altogether have been demonstrated. All
these developments are reflected in the fast-growing field of
PHIP-polarized AAs. However, more work is needed to
provide clean solutions and to increase the concentration and
polarizations, as already achieved by DNP. These challenges
will likely be met by developing dedicated setups that allow
the use of high-pressure hydrogenation,[115,116] catalyst fil-
ters,[30, 117,118] or heterogeneous catalysts.[6, 88] The results ach-
ieved by DNPmay prove to be very helpful to overcome these
hurdles. Another issue is that only a few natural amino acids
have been hyperpolarized so far—this shortcoming may be
addressed by the proton-exchange methods SABRE-RELAY
and PHIP-X.
The hyperpolarization of AAs—fundamental building
blocks of all mammalian life—is intriguing and promises
many insights into biochemistry in vitro and in vivo. Whether
or not hyperpolarization will develop into a widely used tool
to investigate AAs is yet to be seen. Very likely, polarization
levels will improve drastically as the development continues.
Aside from studying metabolism, hyperpolarized AAs have
already been used for angiography[54, 119] and pH imaging.[21] It
will continue to be thrilling to witness the rapid evolution of
NMR and MRI with hyperpolarized amino acids.
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Amino acids and peptides are vital ele-
ments of metabolic and proteomic regu-
lations. Non-invasive NMR and MRI
techniques are highly suited for metabo-
lomics diagnostics, but lack sufficient
sensitivity. This Minireview summarizes
the considerable advances in signal am-
plification through parahydrogen-induced
polarization of amino acids and peptides.
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